BioMaxima Spółka Akcyjna financials

BioMaxima Spółka Akcyjna

Country: PL Reporting currency: PLN Latest annual report: 2023-12-31
LEI: 2594007GAALFMXP4YB89
Source filing ↗
Financial statements (PLN, as reported — unscaled; 128 line items across 2 annual periods)
Line item 20232022
Income statement
Revenue PLN 46.8MPLN 143.9M
Other income PLN 1.6MPLN 1.6M
Employee benefits expense PLN 13.5MPLN 12.5M
Raw materials & consumables used PLN 16.4MPLN 77.7M
Depreciation & amortisation PLN 2.5MPLN 2.0M
Operating profit (EBIT) PLN 728.0KPLN 34.9M
Finance costs PLN 805.0KPLN 486.0K
Profit before tax PLN 187.0KPLN 35.9M
Income tax expense -PLN 399.0KPLN 7.0M
Profit for the year PLN 586.0KPLN 28.9M
— attributable to owners PLN 586.0KPLN 28.9M
— attributable to NCI PLN 0PLN 0
Total comprehensive income -PLN 3.4MPLN 30.2M
Per share
Basic EPS PLN 0.14PLN 6.68
Diluted EPS PLN 0.14PLN 6.48
Free cash flow / share PLN -3.94PLN 6.10
Cash flow statement
Cash generated from operations PLN 1.6MPLN 44.2M
Net cash from operating activities PLN 1.6MPLN 37.1M
Net cash from investing activities -PLN 17.2M-PLN 7.8M
Net cash from financing activities PLN 4.3M-PLN 19.3M
Dividends paid PLN 2.1MPLN 1.9M
Proceeds from borrowings PLN 8.2MPLN 5.0K
Repayments of borrowings PLN 1.3MPLN 10.8M
Lease liability payments PLN 98.0KPLN 1.1M
Net change in cash -PLN 11.4MPLN 9.9M
Balance sheet
Total assets PLN 73.8MPLN 74.4M
Non-current assets PLN 51.0MPLN 38.2M
Property, plant & equipment PLN 50.6MPLN 37.8M
Intangible assets & goodwill PLN 0PLN 0
Current assets PLN 22.8MPLN 36.2M
Inventories PLN 12.8MPLN 12.8M
Trade & other receivables PLN 8.6MPLN 10.1M
Cash & equivalents PLN 1.5MPLN 12.9M
Total equity PLN 47.0MPLN 52.5M
— attributable to owners PLN 47.0MPLN 52.5M
Non-controlling interests PLN 0PLN 0
Non-current liabilities PLN 16.4MPLN 11.0M
Lease liabilities (non-current) PLN 456.0KPLN 249.0K
Current liabilities PLN 10.4MPLN 11.0M
Lease liabilities (current) PLN 247.0KPLN 413.0K
Trade & other payables PLN 5.5MPLN 7.4M
Deferred tax liabilities PLN 334.0KPLN 766.0K
Derived metrics
Free cash flow -PLN 16.5MPLN 27.2M
Operating margin 1.6%24.2%
Net margin 1.3%20.1%
Return on equity 1.2%55.1%
Cash conversion ratio 2.72×1.28×
Capex coverage 0.09×3.75×
Other reported items
Adjustments For Decrease Increase In Inventories -PLN 696.0KPLN 1.0M
Adjustments For Decrease Increase In Trade and Other Receivables PLN 1.2MPLN 4.2M
Adjustments For Depreciation and Amortisation Expense PLN 2.5MPLN 2.0M
Adjustments For Fair Value Gains Losses PLN 0PLN 0
Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss PLN 0PLN 0
Adjustments For Increase Decrease In Trade and Other Payables -PLN 711.0KPLN 753.0K
Adjustments For Interest Expense PLN 606.0KPLN 454.0K
Adjustments For Interest Income PLN 138.0KPLN 811.0K
Adjustments For Losses Gains On Disposal of Noncurrent Assets -PLN 18.0K-PLN 1.0K
Adjustments For Provisions -PLN 1.3MPLN 633.0K
Adjustments For Reconcile Profit Loss PLN 1.4MPLN 8.3M
Adjustments For Sharebased Payments PLN 0PLN 0
Adjustments For Unrealised Foreign Exchange Losses Gains PLN 20.0K-PLN 26.0K
Basic Earnings Loss Per Share From Continuing Operations PLN 0.14PLN 6.68
Basic Earnings Loss Per Share From Discontinued Operations PLN 0.00PLN 0.00
Cash Advances and Loans Made To Other Parties Classified As Investing Activities PLN 0PLN 0
Cash Receipts From Repayment of Advances and Loans Made To Other Parties Classified As Investing Activities PLN 4.0KPLN 10.0K
Changes In Equity -PLN 5.5MPLN 23.3M
Changes In Inventories of Finished Goods and Work In Progress -PLN 1.5MPLN 318.0K
Comprehensive Income Attributable To Noncontrolling Interests PLN 0PLN 0
Comprehensive Income Attributable To Owners of Parent -PLN 3.4MPLN 30.2M
Cost of Merchandise Sold PLN 10.5MPLN 11.5M
Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners PLN 22.8MPLN 36.2M
Current Government Grants PLN 697.0KPLN 477.0K
Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale PLN 10.4MPLN 11.0M
Current Provisions PLN 492.0KPLN 1.4M
Current Tax Assets Current PLN 0PLN 401.0K
Current Tax Liabilities Current PLN 0PLN 0
Deferred Tax Assets PLN 0PLN 0
Diluted Earnings Loss Per Share From Continuing Operations PLN 0.14PLN 6.48
Diluted Earnings Loss Per Share From Discontinued Operations PLN 0.00PLN 0.00
Dividends Received Classified As Investing Activities PLN 0PLN 0
Effect of Exchange Rate Changes On Cash and Cash Equivalents PLN 0PLN 0
Equity and Liabilities PLN 73.8MPLN 74.4M
Finance Income PLN 215.0KPLN 1.5M
Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 -PLN 49.0K-PLN 36.0K
Income Taxes Paid Refund Classified As Operating Activities PLN 32.0KPLN 7.1M
Increase Decrease In Cash and Cash Equivalents -PLN 11.4MPLN 9.9M
Increase Decrease Through Sharebased Payment Transactions PLN 0PLN 0
Increase Decrease Through Treasury Share Transactions PLN 0-PLN 5.0M
Intangible Assets Other Than Goodwill PLN 370.0KPLN 435.0K
Interest Paid Classified As Financing Activities PLN 578.0KPLN 467.0K
Interest Received Classified As Investing Activities PLN 170.0KPLN 811.0K
Issue of Equity PLN 45.0KPLN 9.0K
Issued Capital PLN 4.2MPLN 4.3M
Liabilities PLN 26.8MPLN 22.0M
Liabilities Included In Disposal Groups Classified As Held For Sale PLN 0PLN 0
Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners PLN 0PLN 0
Noncurrent Government Grants PLN 6.9MPLN 6.0M
Noncurrent Provisions PLN 102.0KPLN 93.0K
Other Comprehensive Income -PLN 4.0MPLN 1.3M
Other Comprehensive Income Net of Tax Exchange Differences On Translation PLN 85.0K-PLN 9.0K
Other Comprehensive Income Net of Tax Gains Losses On Revaluation -PLN 4.1MPLN 1.3M
Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax PLN 85.0K-PLN 9.0K
Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax -PLN 4.1MPLN 1.3M
Other Current Financial Assets PLN 0PLN 13.0K
Other Current Financial Liabilities PLN 3.5MPLN 1.3M
Other Expense By Function PLN 201.0KPLN 1.5M
Other Expense By Nature PLN 1.7MPLN 1.8M
Other Noncurrent Financial Assets PLN 0PLN 0
Other Noncurrent Financial Liabilities PLN 8.6MPLN 3.9M
Other Noncurrent Nonfinancial Liabilities PLN 0PLN 0
Other Reserves PLN 95.0KPLN 9.1M
Other Work Performed By Entity and Capitalised PLN 249.0KPLN 1.7M
Payments From Changes In Ownership Interests In Subsidiaries PLN 0PLN 0
Payments To Acquire Or Redeem Entitys Shares PLN 0PLN 5.0M
Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets PLN 18.0KPLN 1.0K
Proceeds From Government Grants Classified As Investing Activities PLN 639.0KPLN 1.2M
Proceeds From Issue of Bonds Notes and Debentures PLN 0PLN 0
Proceeds From Issuing Shares PLN 45.0KPLN 9.0K
Proceeds From Sales of Investments Other Than Investments Accounted For Using Equity Method PLN 0PLN 0
Profit Loss From Continuing Operations PLN 586.0KPLN 28.9M
Profit Loss From Discontinued Operations PLN 0PLN 0
Purchase of Investments Other Than Investments Accounted For Using Equity Method PLN 0PLN 0
Purchase of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets PLN 18.1MPLN 9.9M
Repayments of Bonds Notes and Debentures PLN 0PLN 0
Retained Earnings PLN 32.8MPLN 34.2M
Services Expense PLN 4.7MPLN 5.0M
Share Premium PLN 9.8MPLN 9.8M
Treasury Shares PLN 0PLN 5.0M
Methodology

Every line item above is a fact tagged in BioMaxima Spółka Akcyjna's annual report filed in the European Single Electronic Format (ESEF) under the IFRS taxonomy (ifrs-full) — the income statement, balance sheet and cash-flow statement as the filer reported them. Values are shown as-is, in the reporting currency (PLN), without rescaling; the row labels map to the underlying concept name (e.g. Revenue → ifrs-full:Revenue, Operating profit → ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS → ifrs-full:DilutedEarningsLossPerShare), and any concept without a curated label is shown under “Other reported items” with its de-camel-cased tag name. Only consolidated, default-member facts are shown (segment / dimensional breakdowns are excluded).

“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.

Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.